Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aroa Biosurgery Ltd ( (AU:ARX) ) has provided an announcement.
Aroa Biosurgery Limited, a medtech firm specialising in biosurgical and regenerative tissue products for surgical and wound care applications, is listed on the Australian Securities Exchange under the code ARX. The company has announced the cessation of 6,753 ARXAAK options, which lapsed on 19 October 2025 after conditions attached to the rights were not satisfied, resulting in a small reduction of potential dilutive securities on issue but no change to the existing ordinary share capital.
The most recent analyst rating on (AU:ARX) stock is a Buy with a A$0.90 price target. To see the full list of analyst forecasts on Aroa Biosurgery Ltd stock, see the AU:ARX Stock Forecast page.
More about Aroa Biosurgery Ltd
Aroa Biosurgery Limited is a medical technology company listed on the ASX that develops and commercialises biosurgical products, including tissue repair and regenerative healing solutions, for use in surgical and wound care markets.
Average Trading Volume: 300,983
Technical Sentiment Signal: Buy
Current Market Cap: A$257M
Find detailed analytics on ARX stock on TipRanks’ Stock Analysis page.